Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The alpha-2B adrenergic receptor (α2B adrenoceptor) is a G protein-coupled receptor (GPCR) that belongs to the alpha-2 adrenergic receptor family. It is predominantly located on vascular smooth muscle and plays a key role in vasoconstriction. Activation leads to inhibition of adenylyl cyclase and a reduction in cyclic AMP levels. Polymorphisms in ADRA2B are associated with altered metabolic rate and emotional memory processing. Drugs targeting alpha-2 adrenergic receptors are used for conditions such as hypertension, though selectivity for the α2B subtype varies.
Agonist or antagonist binding leading to altered downstream signaling via G proteins and modulation of adenylyl cyclase activity. Primarily leads to inhibition of norepinephrine release and vasoconstriction.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-2B Adrenergic Receptor (α2B adrenoceptor).